Neuspera Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 26
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $26M
Latest Deal Amount
  • Investors
  • 5

Neuspera General Information

Description

Developer of implantable medical device technology designed to improve the lives of patients battling chronic illness. The company's technology includes implantable neuromodulation devices that use mid-field powering techniques and can be implanted deeper, enabling patients to get treatment options that are less invasive and more adaptable.

Contact Information

Website
www.neuspera.com
Formerly Known As
Vivonda Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Application Software
Primary Office
  • 51 Daggett Drive
  • San Jose, CA 95134
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuspera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 24-Jan-2018 $26M 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 26-Apr-2016 00.000 00.00 000.00 Completed Startup
1. Angel (individual) $1M $1M Completed Startup
To view Neuspera’s complete valuation and funding history, request access »

Neuspera Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Neuspera’s complete cap table history, request access »

Neuspera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of implantable medical device technology designed to improve the lives of patients battling chronic illness. T
Therapeutic Devices
San Jose, CA
26 As of 2020
000.00
000 0000-00-00
00000000000 000.00

00000000

m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et d
00000000000 0000000
Hamburg, Germany
000.00
000000000000 000.00

0000

aboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
00000000000 0000000
Dublin, Ireland
00 As of 0000
00000
0000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuspera Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tinnitracks Venture Capital-Backed Hamburg, Germany 000.00 000000000000 000.00
0000 Venture Capital-Backed Dublin, Ireland 00 00000 0000000000 00000
00000000 Venture Capital-Backed Dublin, Ireland 00 000.00 00000000000 000.00
00000000 Venture Capital-Backed Pompano Beach, FL 000 00000 00000000000 00000
000000000 Corporate Backed or Acquired Berlin, Germany 0000 000000&0
You’re viewing 5 of 25 competitors. Get the full list »

Neuspera Executive Team (5)

Name Title Board Seat Contact Info
Milton Morris Ph.D Chief Executive Officer, President & Board Member
Alexander Yeh Ph.D Founder, Chief Technology Officer & Director
Tim Fayram Vice President of Clinical & Regulatory Affairs
Stephen Schellenberg Vice President, Operations
Tim Ciciarelli Vice President, Research & Development
To view Neuspera’s complete executive team members history, request access »

Neuspera Board Members (5)

Name Representing Role Since
Ching Zhu Ph.D 6 Dimensions Capital Board Member 000 0000
Imran Eba Action Potential Venture Capital Board Member 000 0000
Juan-Pablo Mas Action Potential Venture Capital Board Observer 000 0000
Milton Morris Ph.D Neuspera Chief Executive Officer, President & Board Member 000 0000
To view Neuspera’s complete board members history, request access »

Neuspera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuspera Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
Alumni Ventures Group Venture Capital Minority 000 0000 000000 0
Delta Capital Growth/Expansion Minority 000 0000 000000 0
Action Potential Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
Windham Venture Partners Venture Capital Minority 000 0000 000000 0
To view Neuspera’s complete investors history, request access »

Ready to get started?

Request a free trial